Blood Eosinophils Are Associated with Efficacy of Targeted Therapy in Patients with Advanced Melanoma

Blood Eosinophils Are Associated with Efficacy of Targeted Therapy in Patients with Advanced Melanoma

Background: Eosinophils appear to contribute to the efficacy of immunotherapy and their frequency was suggested as a predictive biomarker. Whether this observation could be transferred to patients treated with targeted therapy remains unknown. Methods: Blood and serum samples of healthy controls and...

Full description

Bibliographic Details
Main Authors: Simone Wendlinger, Jonas Wohlfarth, Sophia Kreft, Claudia Siedel, Teresa Kilian, Ulrich Dischinger, Markus V. Heppt, Kilian Wistuba-Hamprecht, Friedegund Meier, Matthias Goebeler, Dirk Schadendorf, Anja Gesierich, Corinna Kosnopfel, Bastian Schilling
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Cancers
Subjects:
melanoma
eosinophils
biomarker
Online Access:https://www.mdpi.com/2072-6694/14/9/2294

Internet

https://www.mdpi.com/2072-6694/14/9/2294

Similar Items